Robert Kimutai

1.1k total citations
9 papers, 313 citations indexed

About

Robert Kimutai is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Infectious Diseases. According to data from OpenAlex, Robert Kimutai has authored 9 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Public Health, Environmental and Occupational Health, 5 papers in Epidemiology and 2 papers in Infectious Diseases. Recurrent topics in Robert Kimutai's work include Research on Leishmaniasis Studies (5 papers), Trypanosoma species research and implications (5 papers) and HIV/AIDS Research and Interventions (2 papers). Robert Kimutai is often cited by papers focused on Research on Leishmaniasis Studies (5 papers), Trypanosoma species research and implications (5 papers) and HIV/AIDS Research and Interventions (2 papers). Robert Kimutai collaborates with scholars based in Kenya, Netherlands and Switzerland. Robert Kimutai's co-authors include Sassy Molyneux, Helen Nabwera, Amin S. Hassan, James A. Berkley, Eduard J. Sanders, Miriam Taegtmeyer, Monique Wasunna, Thomas P. C. Dorlo, Asrat Hailu and Raymond Omollo and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Robert Kimutai

8 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Kimutai Kenya 8 176 123 120 68 42 9 313
Richard Pendame United States 5 207 1.2× 110 0.9× 45 0.4× 27 0.4× 48 1.1× 6 364
Jessica Kafuko United States 8 153 0.9× 158 1.3× 95 0.8× 118 1.7× 36 0.9× 10 331
Julius N. Kalamya Uganda 6 126 0.7× 202 1.6× 135 1.1× 81 1.2× 55 1.3× 11 348
Edward Bitarakwate United States 8 129 0.7× 158 1.3× 51 0.4× 65 1.0× 78 1.9× 11 372
James Muttunga Kenya 10 34 0.2× 198 1.6× 113 0.9× 137 2.0× 36 0.9× 14 355
Nelson Chimbiya Malawi 5 177 1.0× 157 1.3× 86 0.7× 18 0.3× 52 1.2× 7 351
Orikomaba Obunge Nigeria 8 80 0.5× 161 1.3× 64 0.5× 183 2.7× 24 0.6× 18 359
Kate Grimwade United Kingdom 9 207 1.2× 232 1.9× 172 1.4× 37 0.5× 73 1.7× 14 508
José Cerbino-Neto Brazil 10 142 0.8× 112 0.9× 68 0.6× 21 0.3× 18 0.4× 31 307
Sicelo S. Dlamini South Africa 7 207 1.2× 171 1.4× 116 1.0× 17 0.3× 43 1.0× 13 428

Countries citing papers authored by Robert Kimutai

Since Specialization
Citations

This map shows the geographic impact of Robert Kimutai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Kimutai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Kimutai more than expected).

Fields of papers citing papers by Robert Kimutai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Kimutai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Kimutai. The network helps show where Robert Kimutai may publish in the future.

Co-authorship network of co-authors of Robert Kimutai

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Kimutai. A scholar is included among the top collaborators of Robert Kimutai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Kimutai. Robert Kimutai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Kip, Anke E, Séverine Blesson, Fabiana Alves, et al.. (2021). Low antileishmanial drug exposure in HIV-positive visceral leishmaniasis patients on antiretrovirals: an Ethiopian cohort study. Journal of Antimicrobial Chemotherapy. 76(5). 1258–1268. 7 indexed citations
2.
Verrest, Luka, Anke E Kip, Ahmed Musa, et al.. (2021). Blood Parasite Load as an Early Marker to Predict Treatment Response in Visceral Leishmaniasis in Eastern Africa. Clinical Infectious Diseases. 73(5). 775–782. 19 indexed citations
3.
Mbui, Jane, Joseph Olobo, Raymond Omollo, et al.. (2018). Pharmacokinetics, Safety, and Efficacy of an Allometric Miltefosine Regimen for the Treatment of Visceral Leishmaniasis in Eastern African Children: An Open-label, Phase II Clinical Trial. Clinical Infectious Diseases. 68(9). 1530–1538. 37 indexed citations
4.
Omollo, Raymond, et al.. (2017). PILOTING DHIS2 SYSTEM IN VISCERAL LEISHMANIASIS SURVEILLANCE. BMJ Global Health. 2(Suppl 2). A64.3–A65.
5.
Diro, Ermias, Lutgarde Lynen, Mahlet Assefa, et al.. (2015). Impact of the Use of a Rapid Diagnostic Test for Visceral Leishmaniasis on Clinical Practice in Ethiopia: A Retrospective Study. PLoS neglected tropical diseases. 9(5). e0003738–e0003738. 19 indexed citations
6.
Khalil, Eltahir Awad Gasim, Teklu Weldegebreal, Brima M. Younis, et al.. (2014). Safety and Efficacy of Single Dose versus Multiple Doses of AmBisome® for Treatment of Visceral Leishmaniasis in Eastern Africa: A Randomised Trial. PLoS neglected tropical diseases. 8(1). e2613–e2613. 60 indexed citations
7.
Hassan, Amin S., Helen Nabwera, Miriam Taegtmeyer, et al.. (2011). Dynamics and Constraints of Early Infant Diagnosis of HIV Infection in Rural Kenya. AIDS and Behavior. 16(1). 5–12. 92 indexed citations
8.
Lang, Trudie, Nicholas J. White, Tran Tinh Hien, et al.. (2010). Clinical Research in Resource-Limited Settings: Enhancing Research Capacity and Working Together to Make Trials Less Complicated. PLoS neglected tropical diseases. 4(6). e619–e619. 55 indexed citations
9.
Kibuuka, Hannah, David Guwatudde, Robert Kimutai, et al.. (2009). Contraceptive Use in Women Enrolled into Preventive HIV Vaccine Trials: Experience from a Phase I/II Trial in East Africa. PLoS ONE. 4(4). e5164–e5164. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard Pendame Breakdown of academic impact, for papers by Jessica Kafuko Breakdown of academic impact, for papers by Julius N. Kalamya Breakdown of academic impact, for papers by Edward Bitarakwate Breakdown of academic impact, for papers by James Muttunga Breakdown of academic impact, for papers by Nelson Chimbiya Breakdown of academic impact, for papers by Orikomaba Obunge Breakdown of academic impact, for papers by Kate Grimwade Breakdown of academic impact, for papers by José Cerbino-Neto Breakdown of academic impact, for papers by Sicelo S. Dlamini
Rankless by CCL
2026